• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD. 8010379 DEPUY ASR XL FEM IMP SIZE 45; HIP FEMORAL HEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD. 8010379 DEPUY ASR XL FEM IMP SIZE 45; HIP FEMORAL HEAD Back to Search Results
Catalog Number 999890145
Device Problem Loss of Osseointegration (2408)
Patient Problems Foreign Body Reaction (1868); Pain (1994); No Code Available (3191)
Event Date 12/04/2014
Event Type  Injury  
Event Description
Asr revision, asr xl - right, reason(s) for revision: component loosening, pain.On the scf states under other reasons for revision - high blood chrome and cobolt concentrations and proximal femoral shaft stress changes - ? early fracture.(b)(6) 2015 - rec'd email with demographics for patient, rec'd height, weight, gender,dob, age, new reason for revision - metallosis and stem was component that was loose.
 
Manufacturer Narrative
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Depuy still considers this case closed to capa.
 
Event Description
Asr revision.Asr xl - right.Reason(s) for revision: component loosening, pain.On the scf states under other reasons for revision - high blood chrome and cobalt concentrations and proximal femoral shaft stress changes - ? early fracture.
 
Manufacturer Narrative
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.No 510(k) number provided because this implant is sold internationally with different indications for use; it is currently sold in the us under a different part number.The correction/removal reporting number listed applies to the corresponding product code sold domestically.The asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.Ref.Wwcapa (b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEPUY ASR XL FEM IMP SIZE 45
Type of Device
HIP FEMORAL HEAD
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD. 8010379
st. anthony's rd
leeds LS11 8 D
UK  LS11 8 DT
Manufacturer (Section G)
DEPUY INTERNATIONAL LTD. 8010379
st. anthony's rd
leeds LS11 8 D
UK   LS11 8 DT
Manufacturer Contact
steve dowell
700 orthopaedic drive
warsaw, IN 46581
5743714918
MDR Report Key4354294
MDR Text Key5360225
Report Number1818910-2014-34937
Device Sequence Number1
Product Code KXA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign
Reporter Occupation Patient
Remedial Action Recall
Type of Report Initial,Followup
Report Date 02/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date05/13/2009
Device Catalogue Number999890145
Device Lot Number1195521
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/12/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2004
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-1749/1816-2011
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient Weight75
-
-